Vision
Timely personalized diagnosis, prognosis, and effective treatments accessible to all
Our vision is to pioneer a future where AI-driven healthcare innovations make timely personalized diagnosis, prognosis, and effective treatments accessible to everyone, for a wide range of diseases and clinical conditions.
Mission
Empower & Collaborate
Our Mission is twofold:
1.
Empower healthcare institutions with cutting-edge AI technology to detect disease at its earliest stages, facilitating proactive interventions and improved patient outcomes.
2.
Collaborate with healthcare, medical device and pharmaceutical companies to enhance diagnostic devices and clinical trials, accelerate diagnosis and therapy development, and ultimately bring effective diagnostic devices and treatments to market faster for diseases and clinical conditions.
Value Proposition
Our AI platform offers a transformative AI approach to multifactorial disease diagnosis and prognosis and allows faster therapeutic development.
For Hospitals
For Medical Device Companies
Partnering with us provides access to a robust AI toolset to augment medical device performances, and accelerate the development of innovative medical devices for diagnosis and treatments.
For Pharmaceutical Companies
Overall
Our solution empowers stakeholders across the healthcare ecosystem to address the growing challenges of diseases, fostering better patient outcomes and advancing the forefront of medical innovation.
Milestones
Mar 2020
Officially recognized as the first Spin Off of the University School for Advanced Studies IUSS Pavia
Oct 2019
Patent Application Filed for TRACE4
Jul 2019
PLASTIC-FINDER case study at the Republic of Maldives
Scientific publication in Science of the Total Environment, Elsevier
Sep 2018
Italian Software Patent registered for PLASTIC FINDER
Jul 2018
PROOF OF CONCEPT of PLASTIC FINDER
Presented at the Second Maldives Marine Science Symposium
Jul 2018
1° Commercial Agreement Signed
Jun 2018
START UP is founded
May 2018
PROOF OF CONCEPT of the application of TRACE4AD to MCI patients
Scientific publication in Frontiers in Aging Neuroscience
Aug 2017
START UP incubation in Sylicon Valley
Jul 2017
Italian Software Patent registered for TRACE4AD
Sep 2015
PROOF OF CONCEPT of TRACE4AD
Scientific publication in Frontiers in Neuroscience
Awards
Officially recognized as the first Spin Off of the University School for Advanced Studies IUSS Pavia
Marzotto Award 2019 finalist
Winner of the LifeScience Unicredit StartLab 2019 call.
Finalist of the OpenItaly DemoDay 2019
(top-20 listmaker) (read more).
Top-100 italian-startups listmaker 2018, as selected by StartupItalia.
Finalist of the Startup World Cup 2019 (top-20 listmaker), organised by StartupItalia! and Fenox Venture Capital.
Winner of the Competition "The social impact of computer vision", assigned by the School Directors of the International Computer Vision Summer School (ICVSS), Italy.
Angelo Marai Award, assigned by Fondazione Carlo Erba "to a research doctor who during his doctorate period has developed particularly innovative research and that could form the basis of future programs in the field of neurodegenerative diseases".
Peres Heritage Initiative Award
assigned by the Peres Center for Peace & Innovation in partnership with The European House – Ambrosetti, in recognition "to two young social innovators, entrepreneurs, activists or researchers who stand out for excellent results in the fields consistent with the belief of Shimon: pursuit of peace, green economy and sustainability / circular economy, inclusive business models, non-profit sector, innovation and scientific developments, refugees Integration, social innovation, new challenges in education".
The prize was awarded at The European House – Ambrosetti (Villa d'Este, Cernobbio, Italy), which hosts the initiative within the annual forum "Intelligence of the world, Europe, Italy". The winning project was presented in the presence of heads of state and government, ministers, Nobel prizes, entrepreneurs, managers and experts on issues of major impact for the global economy and society as a whole.
Youth In Action Award
for Sustainable Development Goals, assigned by Fondazione Italiana Accenture, Fondazione Eni Enrico Mattei, and Fondazione Giangiacomo Feltrinelli "in recognition of the innovative, high social and technological impact that will help to achieve the Sustainable Development Goals in Italy", to the project entitled "TRACE4AD: The RAdiologist's Cognitive Eyes for Alzheimer's Disease". Special Prize assigned by Fondazione Bracco.
The project was also selected for a presentation at the Italian Parliament in Rome, during the closing of the Sustainable Development Festival.
3rd finalist in the Competition "A machine-learning neuroimaging challenge for automated diagnosis of Mild Cognitive Impairment", hosted on the Kaggle web platform.
The US - Italy Fulbright Commission Award
for Business Exchange and Students Training (BEST) Program, assigned by Invitalia to the entrepreneurial project "TRACE4AD: The RAdiologist’s Congnitive Eyes for Alzheimer’s Disease". The entrpreneurial project was developed in the Silicon Valley in California, during August 2017-March 2018, at the Santa Clara University Business School.
Forbes 30 Under 30 Award assigned to European Top Leaders, Inventors and Entrepreneurs of Tomorrow by The Forbes Magazine in the category "Science & HealthCare".
Medical Device
Regulation
DeepTrace is also committed to fulfilling regulatory requirements related to the medical device sector and to operate following the relevant guidelines and international standards
